DEF: Nauticus Robotics: $250M Equity Line, Reverse Split Vote

Sentiment:

Proxy Statement


Nauticus Robotics seeks shareholder approval for a $250 million equity purchase facility, a significant reverse stock split, and an increase in authorized shares to address capital needs and Nasdaq listing requirements.

Delay expectedThe Adjournment Proposal explicitly seeks authorization to adjourn the Special Meeting to a later date or dates if there are insufficient votes for other proposals, indicating a potential for delays in implementing critical financial and corporate actions.If stockholder approval for the Series C Preferred Stock issuance is not obtained at the Special Meeting, the company is obligated to hold subsequent meetings every sixty calendar days until approval is secured, potentially delaying full conversion rights and increasing costs.If the ELOC proposal is not approved, the company must adjourn and reconvene the stockholder meeting at least every thirty calendar days until approval is obtained, but no later than 365 days after the Effective Date of the Purchase Agreement.
Capital raiseThe ELOC Proposal seeks approval for an Equity Purchase Facility Agreement to sell up to $250 million of common stock to an institutional investor over a 24-month period.The Nasdaq Stock Issuance Proposal (Series C Preferred Stock) involves the exchange of existing secured convertible term loans and debentures into 3,814 shares of Series C Convertible Preferred Stock, which can then be converted into common stock.The Authorized Shares Proposal to increase authorized common stock from 625,000,000 to 1,500,000,000 is intended to provide sufficient shares for future capital raising activities.
Worse than expectedThe company is seeking approval for measures that indicate significant financial strain, including a large potential dilution from an equity line of credit and convertible preferred stock.A proposed reverse stock split, following a previous one in September 2025, highlights persistent issues with maintaining Nasdaq's minimum bid price requirement.The high dividend rate (10%, potentially 18%) and redemption premium (125%) on the Series C Preferred Stock suggest a high cost of capital, reflecting increased risk perception by investors.The need to increase authorized shares significantly points to a strategy of relying on equity financing, which will further dilute existing shareholders.

Summary

  • Shareholders are invited to a Special Meeting on January 28, 2026, to vote on five key proposals.
  • The ELOC Proposal seeks approval for an Equity Purchase Facility Agreement (dated October 24, 2025) to issue up to $250 million in common stock to an institutional investor over 24 months, requiring Nasdaq Rule 5635 approval due to potential issuance exceeding 20% of outstanding shares at a price below the Minimum Price.
  • The Nasdaq Stock Issuance Proposal (Series C Preferred Stock) requests approval for the issuance of common stock upon conversion of Series C Convertible Preferred Stock (issued December 3, 2025) to certain institutional investors, also requiring Nasdaq Rule 5635 approval due to potential conversion price adjustments below the Minimum Price.
  • The Reverse Split Proposal authorizes the Board to enact one or more reverse stock splits at a cumulative ratio between 1-for-5 and 1-for-250, at its discretion, before the next Annual General Meeting, with fractional shares rounded up.
  • The Authorized Shares Proposal aims to increase the number of authorized Common Stock from 625,000,000 to 1,500,000,000.
  • The Adjournment Proposal seeks authorization to adjourn the Special Meeting if necessary to permit further solicitation and vote of proxies.
  • The Board of Directors unanimously recommends voting FOR all proposals.

Sentiment

Score: 2

Explanation: The company is undertaking multiple actions (large equity line, convertible preferred stock with onerous terms, repeated reverse splits, massive increase in authorized shares) that are typically associated with severe financial distress and a desperate need for capital, leading to substantial shareholder dilution and uncertainty regarding long-term viability.

Positives

  • Securing an Equity Purchase Facility Agreement for up to $250 million provides a potential source of capital for working capital, operating expenses, debt repayment, and general corporate purposes.
  • The Exchange Agreements for Series C Preferred Stock helped the company achieve compliance with Nasdaq's $3.5 million equity requirement, avoiding immediate delisting.
  • The equity line of credit offers flexibility in raising capital compared to traditional equity offerings.

Negatives

  • The ELOC Proposal could result in substantial dilution, with up to 151,515,152 shares of Common Stock potentially issued assuming a price of $1.65 per share.
  • The Series C Preferred Stock conversion could lead to significant dilution, with 4.8 million shares at an initial conversion price of $0.95, or up to 24.1 million shares if the Floor Price of $0.19 applies.
  • The Series C Preferred Stock carries a 10% annual dividend rate, increasing to 18% upon certain triggering events, and a 125% redemption premium upon a Bankruptcy Triggering Event or Company Optional Redemption, indicating a high cost of capital.
  • The need for a reverse stock split (ranging from 1-for-5 to 1-for-250) and an increase in authorized shares suggests ongoing financial challenges and a low stock price, potentially signaling distress.
  • The company previously effected a 1-for-9 reverse split on September 5, 2025, and is still facing potential delisting if the stock price fails to satisfy the Minimum Bid Price Requirement by September 5, 2026.
  • The potential for repeated stockholder meetings to obtain approvals if initial votes are insufficient.

Risks

  • Substantial Dilution: Issuance of common stock under the ELOC and conversion of Series C Preferred Stock will cause significant dilution to existing stockholders' ownership and voting interests.
  • Nasdaq Delisting Risk: Failure to maintain a sufficiently high stock price after a reverse split or to meet other listing requirements could lead to delisting, adversely affecting liquidity and marketability.
  • Inability to Obtain Financing: If proposals are not approved, the company may be unable to satisfy obligations under the Purchase Agreement and Exchange Agreements, potentially preventing it from raising necessary capital.
  • Negative Market Perception: Reverse stock splits can be viewed negatively by investors, potentially leading to further stock price declines and reduced trading liquidity.
  • High Cost of Capital: The terms of the Series C Preferred Stock, including high dividend rates and redemption premiums, represent a costly financing mechanism.
  • Anti-Takeover Effect: The increase in authorized shares and potential issuance of common stock could make it more difficult for a third party to acquire control of the company.
  • Tax Consequences of Reverse Split: Stockholders receiving a rounded-up fractional share may incur a tax event.
  • Cash Repayment Obligations: If the common stock is not listed or an event of default occurs, Series C Preferred Stock may require cash redemption, potentially straining liquidity.

Future Outlook

The company's immediate future outlook is heavily focused on securing additional capital through the proposed equity purchase facility and the conversion of Series C Preferred Stock, as well as maintaining its Nasdaq listing through a potential reverse stock split and increased authorized shares. These actions are critical for funding operations, managing debt, and ensuring continued compliance with exchange requirements.

Management Comments

  • Our Board of Directors unanimously recommends that you vote FOR each of the proposals described in this Proxy Statement.
  • Providing the Company the flexibility to fully issue shares of Common Stock that are issuable pursuant to the Purchase Agreement... is in the best interest of the Company and its stockholders.
  • The Purchase Agreement provides an equity line of credit that will allow the Company to have the flexibility of raising capital and issue shares of Common Stock from time to time in a flexible manner compared to traditional equity offerings.
  • The proceeds received may be used for working capital, operating expenses, debt repayment, other general corporate purposes, and could help the Company increase the stockholders equity, which can ensure the Company continues to comply with the Nasdaq continued listing requirement.
  • The Exchange Agreements... are in the best interests of the Company and its stockholders because of the corresponding increase in the stockholders equity in the Company that will result from the exchanges of the Existing Securities for the Series C Preferred Stock, and the contribution of that additional stockholders equity toward gaining compliance with the Equity Rule.
  • A proposed reverse stock split authorization is desirable to avoid future delisting by NASDAQ or delisting warnings from NASDAQ, and to ensure that shares will be available, if needed, for issuance of grants of equity awards, possible acquisitions of companies, products, or technologies, potential business and financial transactions, and other corporate purposes.
  • An increased market price of our common stock may improve the marketability and liquidity of our common stock and encourage interest and trading in our shares of common stock, as well as bring the price of our common stock to a level commensurate with peer companies.
  • The Authorized Shares Amendment has been prompted by business and financial considerations... and it is the intended purpose of the Authorized Shares Amendment to provide greater flexibility to the Board in considering and planning for our potential future corporate needs.

Industry Context

The company operates in the robotics sector, which is often characterized by high capital expenditure requirements for research, development, and scaling operations. The need for significant capital raises, coupled with repeated reverse stock splits and ongoing Nasdaq compliance challenges, suggests that Nauticus Robotics may be facing difficulties in securing sufficient funding through conventional means or achieving profitability, a common hurdle for early-stage or rapidly expanding technology companies. These actions are indicative of a company striving to maintain its public listing and fund its strategic initiatives amidst market pressures and investor scrutiny.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results for direct assessment against industry benchmarks.
  • The necessity for multiple capital raises, including an equity line of credit and convertible preferred stock with high dividend rates and redemption premiums, along with repeated reverse stock splits to maintain Nasdaq listing, suggests that the company's financial performance and market valuation may be significantly underperforming relative to established, well-capitalized peers in the robotics or technology sector.
  • Such measures are typically employed by companies facing acute financial pressure or struggling to attract investment on more favorable terms.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorized Capital IncreaseProposal to increase authorized Common Stock from 625,000,000 to 1,500,000,000 shares.Upon filing of Certificate of Amendment (if approved)Provides flexibility for future equity issuances but increases potential for dilution and could have anti-takeover effects.
Reverse Stock Split AuthorizationProposal to authorize the Board to enact a reverse stock split at a ratio between 1-for-5 and 1-for-250.Upon filing of Certificate of Amendment (if approved)Aims to maintain Nasdaq listing and improve marketability, but carries risks of negative market perception and reduced liquidity.
Stockholder Approval for Equity IssuancesSeeking stockholder approval for issuances under the Equity Purchase Facility Agreement and Series C Preferred Stock conversions to comply with Nasdaq Rule 5635.Upon stockholder approvalEnsures compliance with Nasdaq rules, enabling critical capital raising, but highlights the dilutive nature of these transactions.

Related Party Transactions

  • The institutional investor in the Equity Purchase Facility Agreement and Series C Preferred Stock transactions (ATW Special Situations II LLC, ATW Special Situations I, LLC, ATW Special Situations III, LLC, Material Impact Fund II, L.P.) are existing stockholders.
  • Antonio Ruiz-Gimenez and Kerry Propper are managing members of entities affiliated with ATW Partners.
  • Adam Sharkawy, a director, is a founder and managing partner at Material Impact Fund II, L.P.
  • Eli Spiro's wife is General Partner of Dumby I L.P., which holds private warrants.

Stakeholder Impact

  • Shareholders: Will experience significant dilution from the issuance of common stock under the ELOC and conversion of Series C Preferred Stock. The reverse stock split will reduce the number of shares owned but not the percentage ownership, though it may affect market perception and liquidity.
  • Creditors (Holders of Existing Securities): The exchange of existing secured convertible term loans and debentures into Series C Preferred Stock alters their investment structure, potentially improving the company's balance sheet for Nasdaq compliance but also converting debt to equity.
  • Company (Nauticus Robotics): Gains access to capital for operations and debt management, and takes steps to maintain its Nasdaq listing, which is crucial for public company status and future financing.
  • Management/Board: Gains flexibility in capital raising and corporate actions, but faces ongoing pressure to improve financial performance and maintain listing compliance.

Next Steps

  • Hold a Special Meeting of Stockholders on January 28, 2026, to vote on the proposed actions.
  • If proposals are approved, proceed with drawing down on the Equity Purchase Facility and converting Series C Preferred Stock.
  • Implement a reverse stock split at a ratio determined by the Board, if approved.
  • File a Certificate of Amendment to increase authorized shares, if approved.
  • File a Form 8-K with final voting results within four business days after the Special Meeting.
  • Maintain compliance with Nasdaq listing rules, including the $3.5 million shareholder equity value requirement until December 19, 2026.
  • File a registration statement for the resale of shares issued under the Equity Purchase Facility within 30 days of the Registration Rights Agreement date.

Key Dates

DateDescription
September 18, 2023Company entered into a convertible senior secured term loan agreement (2023 Term Loan Agreement).
December 31, 2023Company entered into a First Amendment to 2023 Term Loan Agreement, providing an incremental loan of $695,000.
January 30, 2024Company entered into a Second Amendment to Term Loan Agreement and a Second Agreement regarding incremental loans, providing an incremental loan of $3,753,144.
November 4, 2024Company entered into a Securities Purchase Agreement with ATW I to purchase $1,150,000 in principal amount of original issue discount senior secured convertible debentures.
December 11, 2024Company issued additional November 2024 Debentures to ATW II in the aggregate principal amount of $1,000,000.
September 5, 2025One-for-nine reverse split of the Company's outstanding common stock was effected.
October 16, 2025Company received a deficiency letter from Nasdaq for failing to meet the $35,000,000 market value of listed securities requirement.
October 24, 2025Company entered into an Equity Purchase Facility Agreement and a Registration Rights Agreement with an institutional investor.
December 3, 2025Company entered into Amendment and Exchange Agreements with certain institutional investors, issuing 3,814 shares of Series C Preferred Stock.
December 4, 2025Company attended a hearing before a Nasdaq Hearings Panel.
December 19, 2025Nasdaq confirmed the company demonstrated compliance with the equity requirement in Rule 5550(b)(1) and granted continued listing, subject to conditions.
December 22, 2025Record date for stockholders entitled to vote at the Special Meeting.
December 29, 2025Notice of Special Meeting, proxy statement, and form of proxy first mailed to stockholders.
January 17, 2026Deadline for a special meeting of stockholders to seek approval for Series C Preferred Stock issuance if not obtained earlier.
January 27, 2026Deadline for Internet or telephone proxy submissions (11:59 P.M. ET).
January 28, 2026Special Meeting of Stockholders to be held at 10 a.m. Central Time.
March 3, 2026Deadline for an additional stockholder meeting if Series C approval is not obtained at the Special Meeting.
April 14, 2026End of Nasdaq Hearings Panel jurisdiction, requiring compliance with all Exchange Listing Rules.
September 5, 2026Deadline for satisfying the Minimum Bid Price Requirement to avoid delisting without a compliance period, given the prior reverse split.
December 19, 2026Company must maintain a shareholder equity value of $3.5 million for each fiscal quarter until this date.
September 5, 2027If another reverse split with a cumulative ratio of 250:1 or more is implemented by this date, and the price fails to meet the Minimum Bid Price Requirement, the company will not be eligible for a compliance period.

Recommendation

strong sell

The filing reveals a company in a precarious financial position, undertaking multiple highly dilutive actions to secure capital and maintain its Nasdaq listing. The proposed $250 million equity line, coupled with the conversion of Series C Preferred Stock (with high dividend rates and redemption premiums), indicates a desperate need for funding that will severely dilute existing shareholders. The necessity for a second reverse stock split within a short period, along with a massive increase in authorized shares, further underscores the company's struggle to achieve a sustainable stock price and financial health. These measures suggest a high risk of further value erosion for current equity holders, making the stock a strong sell.

Keywords

Nauticus Robotics, equity purchase facility, ELOC, Series C Preferred Stock, convertible preferred stock, reverse stock split, authorized shares, capital raise, dilution, Nasdaq listing, corporate governance, shareholder meeting, KITT, robotics

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.